It has been 10 years since GMFH was launched with the aim of disseminating the latest gut microbiome research to the lay public, healthcare professionals and scientists alike. In this article, members of the GMFH board of experts share their pick of the most significant advances in the field, outlining their clinical impact and implications for further research.

Research on the gut microbiome has mainly focused on bacteria, while other key microorganisms such as fungi have been largely overlooked. Learn more about the fungal microbiota’s relevance for health, how it develops across the lifespan and how you can take care of it.

Clostridioides difficile infection is a common cause of diarrhea in both the hospital and community settings, with C. difficile recurrence one of the most challenging outcomes to address. This article focuses on the factors that predict long-term complications of C. difficile infection and what can be done in clinical practice to minimize them (Part 5).

Changes in the gut microbiome have been associated with conditions that cause bone loss or increase fracture risk. Learn more about the role of the gut microbiota in bone health and what today’s science says about the manipulation of the gut microbiota by oral probiotics to prevent bone loss.

Bacterial extracellular vesicles: future postbiotics?

18 Oct 2022

by Konstantina Zafeiropoulou

Research into microbial extracellular vesicles has progressed significantly over several decades. Following up on the 1989 breakthrough that bacterial extracellular vesicles contain genetic information, and the recent ISAPP definition on postbiotics, current research suggests bacterial extracellular vesicles derived from probiotic bacteria may be the postbiotics of the future with potential health benefits.

Go to Top